Simon Leveille - Publications
Affiliations: | 2012 | Microbiology | McGill University, Montreal, QC, Canada |
Year | Citation | Score | |||
---|---|---|---|---|---|
2011 | Leveille S, Goulet ML, Lichty BD, Hiscott J. Vesicular stomatitis virus oncolytic treatment interferes with tumor-associated dendritic cell functions and abrogates tumor antigen presentation. Journal of Virology. 85: 12160-9. PMID 21917977 DOI: 10.1128/Jvi.05703-11 | 0.506 | |||
2011 | Leveille S, Samuel S, Goulet ML, Hiscott J. Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy. Cancer Gene Therapy. 18: 435-43. PMID 21394109 DOI: 10.1038/cgt.2011.14 | 0.45 | |||
2008 | Nguyên TL, Abdelbary H, Arguello M, Breitbach C, Leveille S, Diallo JS, Yasmeen A, Bismar TA, Kirn D, Falls T, Snoulten VE, Vanderhyden BC, Werier J, Atkins H, Vähä-Koskela MJ, et al. Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proceedings of the National Academy of Sciences of the United States of America. 105: 14981-6. PMID 18815361 DOI: 10.1073/Pnas.0803988105 | 0.519 | |||
2008 | Leveille S, Hiscott J. 345 Gentically engineered oncolytic vesicular stomatitis virus to stimulate anti-tumor immune response Cytokine. 43: 325. DOI: 10.1016/J.Cyto.2008.07.429 | 0.496 | |||
2008 | Nakhaei P, Mesplède T, Sun Q, Leveillé S, Korneluk RG, Hiscott J. 10 X-linked inhibitor of apoptosis protein inhibits RIG-I signalling pathway Cytokine. 43: 239. DOI: 10.1016/J.Cyto.2008.07.050 | 0.403 | |||
2007 | Holm GH, Zurney J, Tumilasci V, Leveille S, Danthi P, Hiscott J, Sherry B, Dermody TS. Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. The Journal of Biological Chemistry. 282: 21953-61. PMID 17540767 DOI: 10.1074/Jbc.M702112200 | 0.471 | |||
Show low-probability matches. |